PubRank

Zoltan Szallasi

Author PubWeight™ 157.38‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 2006 30.90
2 An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat 2009 7.91
3 A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 2006 7.16
4 Reliability and reproducibility issues in DNA microarray measurements. Trends Genet 2005 6.79
5 Robustness of cellular functions. Cell 2004 6.65
6 Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer. J Clin Oncol 2010 5.50
7 Sequence-matched probes produce increased cross-platform consistency and more reproducible biological results in microarray-based gene expression measurements. Nucleic Acids Res 2004 4.43
8 Chromosomal instability confers intrinsic multidrug resistance. Cancer Res 2011 3.70
9 Redefinition of Affymetrix probe sets by sequence overlap with cDNA microarray probes reduces cross-platform inconsistencies in cancer-associated gene expression measurements. BMC Bioinformatics 2005 3.66
10 A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexes. Proc Natl Acad Sci U S A 2008 3.57
11 Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. Nat Med 2010 2.62
12 Chromosomal instability determines taxane response. Proc Natl Acad Sci U S A 2009 2.12
13 Jetset: selecting the optimal microarray probe set to represent a gene. BMC Bioinformatics 2011 2.09
14 Paradoxical relationship between chromosomal instability and survival outcome in cancer. Cancer Res 2011 2.05
15 Increased measurement accuracy for sequence-verified microarray probes. Physiol Genomics 2004 1.75
16 Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials. Lancet Oncol 2010 1.57
17 Evaluation of microarray preprocessing algorithms based on concordance with RT-PCR in clinical samples. PLoS One 2009 1.55
18 Replacing cRNA targets with cDNA reduces microarray cross-hybridization. Nat Biotechnol 2006 1.49
19 Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma. Cancer Immunol Immunother 2014 1.42
20 Parallel evolution of tumour subclones mimics diversity between tumours. J Pathol 2013 1.42
21 Relationship of extreme chromosomal instability with long-term survival in a retrospective analysis of primary breast cancer. Cancer Epidemiol Biomarkers Prev 2011 1.38
22 Correction of technical bias in clinical microarray data improves concordance with known biological information. Genome Biol 2008 1.27
23 Targeting chromosomal instability and tumour heterogeneity in HER2-positive breast cancer. J Cell Biochem 2010 1.25
24 Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasets. Genome Med 2010 1.12
25 Tumor mutation burden forecasts outcome in ovarian cancer with BRCA1 or BRCA2 mutations. PLoS One 2013 1.11
26 Prognostic and predictive markers in metastatic renal cell carcinoma. J Clin Oncol 2013 1.08
27 Minimising immunohistochemical false negative ER classification using a complementary 23 gene expression signature of ER status. PLoS One 2010 0.97
28 Optimization of the BLASTN substitution matrix for prediction of non-specific DNA microarray hybridization. Nucleic Acids Res 2009 0.92
29 In silico prediction of tumor antigens derived from functional missense mutations of the cancer gene census. Oncoimmunology 2012 0.92
30 Deconvoluting complex tissues for expression quantitative trait locus-based analyses. Philos Trans R Soc Lond B Biol Sci 2013 0.87
31 Simultaneous suppression of epidermal growth factor receptor and c-erbB-2 reverses aneuploidy and malignant phenotype of a human ovarian carcinoma cell line. Cancer Res 2004 0.85
32 CERT depletion predicts chemotherapy benefit and mediates cytotoxic and polyploid-specific cancer cell death through autophagy induction. J Pathol 2011 0.83
33 Functional genomic analysis of drug sensitivity pathways to guide adjuvant strategies in breast cancer. Breast Cancer Res 2008 0.83
34 Biasogram: visualization of confounding technical bias in gene expression data. PLoS One 2013 0.81
35 Consistent metagenes from cancer expression profiles yield agent specific predictors of chemotherapy response. BMC Bioinformatics 2011 0.81
36 Concordance of exon array and real-time PCR assessment of gene expression following cancer cell cytotoxic drug exposure. Cell Cycle 2008 0.78
37 A survey of methods for classification of gene expression data using evolutionary algorithms. Expert Rev Mol Diagn 2006 0.77
38 A breast cancer meta-analysis of two expression measures of chromosomal instability reveals a relationship with younger age at diagnosis and high risk histopathological variables. Oncotarget 2011 0.76
39 Trading "wet-work" for network. Nat Biotechnol 2002 0.75
40 Assessing the significance of consistently mis-regulated genes in cancer associated gene expression matrices. Bioinformatics 2002 0.75
41 Build your own (virtual) cell. Trends Pharmacol Sci 2002 0.75